SCHEMBL7374338

SCHEMBL7374338

[CH2]c1cccc(-n2ncc(NC)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ELOVL1 Q9BW60 1/20 0.33
GRM5 P41594 1/20 0.32
P2RX7 Q99572 1/20 0.32
FYN P06241 1/20 0.30
MKNK1 Q9BUB5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7381168 0.84 ADORA2A (0.37) ADORA2AADORA1ELOVL1GRM5P2RX7
SCHEMBL28043733 0.80 P2RX7 (0.49) ADORA2AADORA1MEN1NPC1ALDH1A1
SCHEMBL7372783 0.79 P2RX7 (0.34) ADORA2AADORA1MEN1NPC1ALDH1A1
SCHEMBL7380141 0.76 P2RX7 (0.34) MEN1NPC1ALDH1A1LMNAGAA
SCHEMBL7370991 0.75 LSS (0.32) GRM5P2RX7
SCHEMBL7377818 0.75 P2RX7 (0.45) GRM5P2RX7
SCHEMBL7380060 0.72 P2RX7 (0.33) KMT2AGRM5P2RX7
SCHEMBL7376072 0.70 ACLY (0.35) MEN1NPC1ALDH1A1LMNAGAA
SCHEMBL7374400 0.68 ADORA2A (0.37) ADORA2AADORA1MEN1NPC1ALDH1A1
SCHEMBL8470236 0.66 PDPK1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO disclosed